What determines the natural history of recurrent hepatitis C after liver transplantation?

Long-Term Outcome of Hepatitis C Infection after Liver Transplantation

1996 • 986 citations

HCV-related fibrosis progression following liver transplantation: increase in recent years

2000 • 750 citations

Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients

2002 • 607 citations

Natural History of Clinically Compensated Hepatitis C Virus–Related Graft Cirrhosis After Liver Transplantation

2000 • 553 citations

Hepatitis C virus kinetics during and immediately after liver transplantation

2002 • 510 citations

Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes

2003 • 507 citations

Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on Liver Transplantation and Hepatitis C

2003 • 440 citations

Hepatitis C and liver transplantation

2001 • 285 citations

Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C

2002 • 280 citations

Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up

2004 • 276 citations

Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C

2002 • 241 citations

The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients

2003 • 219 citations

A model to predict severe HCV-related disease following liver transplantation

2003 • 200 citations

Liver Transplantation for Hepatitis C: Recurrence and Disease Progression in 300 Patients

2000 • 192 citations

Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1

2003 • 166 citations

Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C1

2004 • 156 citations

Anti[ndash ]Interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation

2001 • 146 citations

Incidence of Hepatitis C in Patients Receiving Different Preparations of Hepatitis B Immunoglobulins after Liver Transplantation

1998 • 144 citations

A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C

2002 • 140 citations

Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation

2002 • 136 citations

The role of immunosuppression in recurrence of hepatitis C

2003 • 135 citations

Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: A prospective, randomized trial

2004 • 131 citations

Transplantation for alcoholic liver disease

2002 • 125 citations

Host and donor risk factors before and after liver transplantation that impact HCV recurrence

2003 • 97 citations

Mechanisms of HCV reinfection and allograft damage after liver transplantation

2004 • 95 citations

Beneficial Effect of Angiotensin-Blocking Agents on Graft Fibrosis in Hepatitis C Recurrence after Liver Transplantation

2004 • 91 citations

THE INFLUENCE OF HLA DONOR-RECIPIENT COMPATIBILITY ON THE RECURRENCE OF HBV AND HCV HEPATITIS AFTER LIVER TRANSPLANTATION1

1995 • 86 citations

A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection

2004 • 86 citations

Prolonged Rewarming Time During Allograft Implantation Predisposes to Recurrent Hepatitis C Infection After Liver Transplantation

2000 • 86 citations

The influence of hepatitis C virus genotypes on the outcome of liver transplantation

1998 • 84 citations

Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence

2003 • 70 citations

Delayed onset of severe hepatitis C-related liver damage following liver transplantation: A matter of concern?

2003 • 53 citations

EFFECT OF ANTIMETABOLITE IMMUNOSUPPRESSANTS ON FLAVIVIRIDAE, INCLUDING HEPATITIS C VIRUS

2004 • 53 citations

Histological recurrence and progression of hepatitis C after orthotopic liver transplantation: Influence of immunosuppressive regimens

2001 • 49 citations

DONOR POLYMORPHISM OF TUMOR NECROSIS FACTOR GENE

1999 • 42 citations

The use of hepatitis C-infected grafts in liver transplantation

2003 • 42 citations

Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation

2000 • 41 citations

Donor‐recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation

1998 • 41 citations

INFLUENCE OF LIVER HEPATITIS C VIRUS RNA AND HEPATITIS C VIRUS GENOTYPE ON FAS-MEDIATED APOPTOSIS AFTER LIVER TRANSPLANTATION FOR HEPATITIS C

2000 • 37 citations

Hepatitis C Virus Quasi‐Species Dynamics Predict Progression of Fibrosis after Liver Transplantation

2004 • 37 citations

Genetic Clustering of Hepatitis C Virus Strains and Severity of Recurrent Hepatitis after Liver Transplantation

2001 • 28 citations

Genetic variability of hepatitis C virus NS3 protein in human leukocyte antigen-A2 liver transplant recipients with recurrent hepatitis C

2004 • 22 citations

Should living donor liver transplantation be offered to patients with hepatitis C virus cirrhosis?

2005 • 22 citations

Evaluation of donor hepatic iron concentration as a factor of early fibrotic progression after liver transplantation

2004 • 9 citations

Living Donor Liver Transplantation for Patients With Hepatitis C Virus Cirrhosis: Tokyo Experience

2005 • 4 citations

Deleted Work

1955 • 0 citations